153 related articles for article (PubMed ID: 16081584)
1. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
Zhang P; Zhang J; Young CY; Kao PC; Chen W; Jiang A; Zhang L; Guo Q
Ann Clin Lab Sci; 2005; 35(3):278-84. PubMed ID: 16081584
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
3. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
[TBL] [Abstract][Full Text] [Related]
4. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
Guth SE; Böhm S; Mussler BH; Eisenbrand G
Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
[TBL] [Abstract][Full Text] [Related]
5. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 in patients with prostate cancer.
Takeshi U; Sadar MD; Suzuki H; Akakura K; Sakamoto S; Shimbo M; Suyama T; Imamoto T; Komiya A; Yukio N; Ichikawa T
Anticancer Res; 2005; 25(6C):4595-8. PubMed ID: 16334148
[TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.
Cheng H; Snoek R; Ghaidi F; Cox ME; Rennie PS
Cancer Res; 2006 Nov; 66(21):10613-20. PubMed ID: 17079486
[TBL] [Abstract][Full Text] [Related]
8. Specific block of androgen receptor activity by antisense oligonucleotides.
Hamy F; Brondani V; Spoerri R; Rigo S; Stamm C; Klimkait T
Prostate Cancer Prostatic Dis; 2003; 6(1):27-33. PubMed ID: 12664061
[TBL] [Abstract][Full Text] [Related]
9. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
10. Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene.
Zhang S; Murtha PE; Young CY
Biochem Biophys Res Commun; 1997 Feb; 231(3):784-8. PubMed ID: 9070893
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia increases androgen receptor activity in prostate cancer cells.
Park SY; Kim YJ; Gao AC; Mohler JL; Onate SA; Hidalgo AA; Ip C; Park EM; Yoon SY; Park YM
Cancer Res; 2006 May; 66(10):5121-9. PubMed ID: 16707435
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of the expression of prostate specific antigen by curcumin].
Yang L; Zhang LY; Chen WW; Kong F; Zhang PJ; Hu XY; Zhang JY; Cui FA
Yao Xue Xue Bao; 2005 Sep; 40(9):800-3. PubMed ID: 16342680
[TBL] [Abstract][Full Text] [Related]
13. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
14. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus.
Kim J; Jia L; Stallcup MR; Coetzee GA
J Mol Endocrinol; 2005 Feb; 34(1):107-18. PubMed ID: 15691881
[TBL] [Abstract][Full Text] [Related]
15. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
16. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
17. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
18. Suppression of mutant androgen receptors by flutamide.
Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
Tsui KH; Feng TH; Chung LC; Chao CH; Chang PL; Juang HH
Anticancer Res; 2008; 28(4A):1969-76. PubMed ID: 18649734
[TBL] [Abstract][Full Text] [Related]
20. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]